VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 121 filers reported holding VERVE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,619 | +5.1% | 259,626 | 0.0% | 0.12% | -7.8% |
| Q3 2023 | $3,443 | -29.3% | 259,626 | 0.0% | 0.13% | -27.7% |
| Q2 2023 | $4,868 | +30.0% | 259,626 | 0.0% | 0.18% | +22.9% |
| Q1 2023 | $3,744 | -25.5% | 259,626 | -0.0% | 0.14% | -30.1% |
| Q4 2022 | $5,024 | -99.9% | 259,637 | +0.0% | 0.21% | -52.9% |
| Q3 2022 | $8,918,000 | – | 259,626 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,008,809 | $37,665,169 | 23.26% |
| Alphabet Inc. | 10,549,086 | $197,795,362 | 10.63% |
| Casdin Capital, LLC | 2,360,571 | $44,260,706 | 3.87% |
| MPM BioImpact LLC | 857,940 | $16,086,375 | 3.24% |
| Redmile Group, LLC | 1,061,960 | $19,911,750 | 0.76% |
| Novo Holdings A/S | 500,000 | $9,375,000 | 0.72% |
| ARK Investment Management | 5,150,851 | $96,578,455 | 0.64% |
| Avidity Partners Management LP | 878,600 | $16,473,750 | 0.58% |
| Nikko Asset Management Americas, Inc. | 2,185,857 | $40,941,102 | 0.43% |
| Cormorant Asset Management, LP | 350,000 | $6,562,500 | 0.37% |